Quality control in quantitation of components of the plasminogen activator system in tumour extracts
- 1 June 1996
- journal article
- Published by Elsevier in Fibrinolysis
- Vol. 10, 149-151
- https://doi.org/10.1016/s0268-9499(96)80073-7
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1: Predictors of Poor Response to Tamoxifen Therapy in Recurrent Breast CancerJNCI Journal of the National Cancer Institute, 1995
- Enzyme-linked immunosorbent assay of urokinase-type plasminogen activator (uPA) in cytosolic extracts of human breast cancer tissueBreast Cancer Research and Treatment, 1993
- Multiparametric Prognostic Evaluation of Biological Factors in Primary Breast CancerJNCI Journal of the National Cancer Institute, 1992
- Fibrinolysis: Past and Present, a Reflection of Fifty YearsSeminars in Thrombosis and Hemostasis, 1991
- Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancerFibrinolysis, 1990
- Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary reportCancer, 1988
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Plasminogen Activators, Tissue Degradation, and CancerPublished by Elsevier ,1985